Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOLS | Common Stock, $0.00001 par value per share | Sale | -$12.7M | -1.69M | -33.33% | $7.50 | 3.38M | Oct 16, 2023 | Direct |
Medytox Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.